These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36542412)

  • 81. Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations.
    Elkhoury FF; Rambhatla A; Mills JN; Rajfer J
    Urology; 2017 Dec; 110():1-8. PubMed ID: 28774772
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic.
    Corona G; Mannucci E; Petrone L; Ricca V; Balercia G; Mansani R; Chiarini V; Giommi R; Forti G; Maggi M
    Int J Impot Res; 2006; 18(2):190-7. PubMed ID: 16136189
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
    Jones TH; Arver S; Behre HM; Buvat J; Meuleman E; Moncada I; Morales AM; Volterrani M; Yellowlees A; Howell JD; Channer KS;
    Diabetes Care; 2011 Apr; 34(4):828-37. PubMed ID: 21386088
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.
    Yaron M; Greenman Y; Rosenfeld JB; Izkhakov E; Limor R; Osher E; Shenkerman G; Tordjman K; Stern N
    Eur J Endocrinol; 2009 May; 160(5):839-46. PubMed ID: 19174534
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone.
    Fallara G; Pozzi E; Belladelli F; Corsini C; Boeri L; Capogrosso P; Montorsi F; Salonia A
    J Sex Med; 2022 Aug; 19(8):1243-1254. PubMed ID: 35753891
    [TBL] [Abstract][Full Text] [Related]  

  • 87. THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.
    Corona G; Giagulli VA; Maseroli E; Vignozzi L; Aversa A; Zitzmann M; Saad F; Mannucci E; Maggi M
    Eur J Endocrinol; 2016 Mar; 174(3):R99-116. PubMed ID: 26537862
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study.
    Krysiak R; Kowalcze K; Okopień B
    J Clin Pharm Ther; 2021 Dec; 46(6):1764-1775. PubMed ID: 34490645
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.
    Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S
    Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Risk of Erythrocytosis During Concomitant Testosterone and SGLT2-Inhibitor Treatment: A Warning From Two Clinical Cases.
    Motta G; Zavattaro M; Romeo F; Lanfranco F; Broglio F
    J Clin Endocrinol Metab; 2019 Mar; 104(3):819-822. PubMed ID: 30395251
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.
    Kapoor D; Channer KS; Jones TH
    Diab Vasc Dis Res; 2008 Jun; 5(2):135-7. PubMed ID: 18537102
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Short term testosterone replacement therapy improves libido and body composition.
    Andrade ES; Clapauch R; Buksman S
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):996-1004. PubMed ID: 20126853
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
    Chrysant SG; Chrysant GS
    Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease.
    Raza MT; Sharif S; Khan ZA; Naz S; Mushtaq S; Umer A
    Cureus; 2019 Dec; 11(12):e6500. PubMed ID: 32025421
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men.
    Corona G; Bianchini S; Sforza A; Vignozzi L; Maggi M
    Hormones (Athens); 2015; 14(4):569-78. PubMed ID: 26732155
    [TBL] [Abstract][Full Text] [Related]  

  • 97. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study.
    Corona G; Rastrelli G; Balercia G; Lotti F; Sforza A; Monami M; Forti G; Mannucci E; Maggi M
    J Sex Med; 2012 Jun; 9(6):1669-80. PubMed ID: 22489756
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
    Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
    Corona G; Mannucci E; Forti G; Maggi M
    Int J Androl; 2009 Oct; 32(5):431-41. PubMed ID: 19538523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.